Last month, Bayer shares were put through their paces by analysts.
Last month, 9 experts submitted their analysis of Bayer shares.
8 analysts recommend buying Bayer shares, 1 expert recommends holding the shares.
The experts’ average price target is EUR 50.00. This represents an increase of EUR 11.95 to the current XETRA price of Bayer shares of EUR 38.05.
The 6-month rating trend indicates Buy.
| Analyst | Price target | Distance price target | Date | |
|---|---|---|---|---|
| UBS AG | 52.00 EUR | 36.66 | April 29, 2026 | |
| JP Morgan Chase & Co. | 50.00 EUR | 31.41 | April 28, 2026 | |
| Barclays Capital | 48.00 EUR | 26.15 | April 28, 2026 | |
| UBS AG | 52.00 EUR | 36.66 | April 28, 2026 | |
| Barclays Capital | 48.00 EUR | 26.15 | April 24, 2026 | |
| JP Morgan Chase & Co. | 50.00 EUR | 31.41 | April 21, 2026 | |
| Goldman Sachs Group Inc. | 55.00 EUR | 44.55 | April 20, 2026 | |
| Deutsche Bank AG | 43.00 EUR | 13.01 | April 16, 2026 | |
| UBS AG | 52.00 EUR | 36.66 | April 13, 2026 | |
| DZ BANK | – | – | 04/09/2026 |
Editorial team finanzen.net
Selected leverage products on Bayer
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Bayer
The leverage must be between 2 and 20
Advertising
